Merck CEO Rob Davis Talks Winrevair Approval

 

Merck CEO Rob Davis joins Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss the approval of the company's treatment for high blood pressure called Winrevair. 

Loading transcript